retatrutide triple agonist obesity phase 2 trial Eli Lilly's 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments retatrutide mechanism triple agonist gip

Taurine deficiency showed an increased level of glucose uptake during treadmill running and glycolysis, resulting in elevated lactate production, which further contributed to impairing the exercise performance (Ito et al., 2014)

Month one: foundation building Don't expect visible changes in the first month

We recommend having your Vitamin B12 Levels checked before beginning treatment (Vitamin B12 blood test available here)

pEC 50 values were calculated using the three parameter log(agonist) vs response model in GraphPad Prism9 (version 9.1.0

Int J Mol Sci 22(5):2596

Phase 3: Taper or Stop (Weeks 9+) At week 810, evaluate: is the injury improving